A prospective research study to collect images from oral cavity of participating subjects to build an artificial intelligence-based tool for supporting the early detection of oral cancers.

Oraicle Biosciences Limited0 个研究点目标入组 3,000 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•A subject will be considered eligible for inclusion in this study only if ALL of the following criteria apply:
•1. Subject (or legally acceptable representative) understands and agrees to comply with planned study procedures and provides informed consent prior to initiation of study procedures
•2. Male & Female adults =18 to < 65 years of age at the time of screening & enrolment.
•3. Subject reporting to the site with some kind of oral lesions.

•A subject will not be eligible for inclusion in this study if ANY of the following criteria apply:
•1. If the subject has participated in another clinical trial in the last 8 weeks before coming at Visit 1.
•2. Subject having any other reason which may interfere with the study in the opinion of the Principal Investigator.
•3. Subject is blind or falls under the category of vulnerable population. e.g., members of a group with hierarchical structure (e.g. prisoners armed forces personnel, staff and students of medical, nursing and pharmacy academic institutions), patients with incurable diseases, unemployed or impoverished persons, patients in emergency situation, ethnic minority groups, homeless persons, nomads, refugees, minors or other incapable of personally giving consent.
•4. If the subject’s mouth does not open wide enough for oral cavity examinations and image acquisition.
•5. If according to the judgment of the investigator Subject needs more than 2 biopsy(ies) for assessment after informed consent and oral cavity examination
•6. Subjects for whom biopsy(ies) were done for the target lesion(s) more than 60 days from the date of consent.
•7. Pregnant or breastfeeding female subjects.

发起方

Oraicle Biosciences Limited